Dr. Araujo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Alabama Medical CenterResidency, Internal Medicine, 1999 - 2002
University of Arkansas For Medical Sciences College of MedicineClass of 1999
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2002 - 2025
OK State Medical License 2020 - 2021
AL State Medical License 2001 - 2002- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas Start of enrollment: 2006 Nov 01
- Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Start of enrollment: 2011 Apr 01
- ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors Start of enrollment: 2019 May 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Epidemiological trends of synovial sarcoma by primary tumor sites in the US from 2000 to 2020.Riddhi R Patel, George L Delclos, Stacia M DeSantis, Michael B Cannell, Philip J Lupo
Cancer Epidemiology. 2024-10-01 - Safety and Efficacy of Percutaneous Cryoablation for Recurrent or Metastatic Soft-Tissue Sarcoma in Adult Patients.Koustav Pal, Ahmed Awad, Steven Yevich, Joshua D Kuban, Alda L Tam
AJR. American Journal of Roentgenology. 2024-10-01 - Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?Riddhi R Patel, George L Delclos, Stacia M DeSantis, Michael B Cannell, Philip J Lupo
American Journal of Clinical Oncology. 2024-09-03
Press Mentions
Newest Research in SarcomaMay 30th, 2024- Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor DayNovember 20th, 2020
Becoming a Mom After Sarcoma Treatment Has Been My Greatest GiftApril 25th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
